GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Now Corp (OTCPK:NWPN) » Definitions » Debt-to-Equity

The Now (The Now) Debt-to-Equity : -0.23 (As of Sep. 2015)


View and export this data going back to . Start your Free Trial

What is The Now Debt-to-Equity?

The Now's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.23 Mil. The Now's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2015 was $0.00 Mil. The Now's Total Stockholders Equity for the quarter that ended in Sep. 2015 was $-0.97 Mil. The Now's debt to equity for the quarter that ended in Sep. 2015 was -0.23.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for The Now's Debt-to-Equity or its related term are showing as below:

NWPN's Debt-to-Equity is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.3
* Ranked among companies with meaningful Debt-to-Equity only.

The Now Debt-to-Equity Historical Data

The historical data trend for The Now's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Now Debt-to-Equity Chart

The Now Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Debt-to-Equity
Get a 7-Day Free Trial N/A N/A 0.01 0.05 0.05

The Now Quarterly Data
Dec07 Dec08 Dec09 Dec10 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Sep14 Sep15
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.05 0.05 N/A -0.23

Competitive Comparison of The Now's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, The Now's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The Now's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Now's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where The Now's Debt-to-Equity falls into.



The Now Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

The Now's Debt to Equity Ratio for the fiscal year that ended in Dec. 2013 is calculated as

The Now's Debt to Equity Ratio for the quarter that ended in Sep. 2015 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


The Now  (OTCPK:NWPN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


The Now Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of The Now's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


The Now (The Now) Business Description

Traded in Other Exchanges
N/A
Address
3400 Pan American Drive, Unit 53, Miami, FL, USA, 33133
The Now Corp is a biopharmaceutical research company. The company focused on the research, education, and production of Scientific-Grade Cannabidiol (CBD) from hemp and Tetrahydrocannabinol (THC) to be used for medicinal purposes. It provides Credible Scientific Research Data to the heavily regulated medical and recreational marijuana industries.

The Now (The Now) Headlines